We are live on
!
Find out more
Kiniksa Pharmaceuticals
KNSA
KNSA
77 hedge funds and large institutions have $274M invested in Kiniksa Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
167% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 9
64% more capital invested
Capital invested by funds: $167M → $274M (+$107M)
24% more funds holding
Funds holding: 62 → 77 (+15)
8.01% more ownership
Funds ownership: 78.75% → 86.76% (+8%)
4% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 23
Holders
77
Holders Change
+15
Holders Change %
+24.19%
% of All Funds
1.7%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
22
Reduced
23
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$35.1M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$11.9M |
| 3 |
LPC
Lion Point Capital
New York
|
+$7.76M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$5.62M |
| 5 |
SCA
Spearhead Capital Advisors
Wellington,
Florida
|
+$4.24M |
Top Sellers
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$15.8M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$7.8M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$4.29M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$3.71M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$3.29M |
